Audrey Schreiber-Bontemps, Marion Roquet, Béatrice Médée, Stéphane Verdun, Katelyne Hubeaux
Services de Médecine Physique et de Réadaptation et Explorations fonctionnelles, CHRU de Brest, Brest, France.
Services de Médecine Physique et de Réadaptation et Explorations fonctionnelles, Centre de Perharidy, Fondation Ildys Roscoff, Roscoff, France.
Sex Med. 2022 Jun;10(3):100502. doi: 10.1016/j.esxm.2022.100502. Epub 2022 Apr 1.
Sexual dysfunction is a common complaint in female with multiple sclerosis (MS), however this problem is not often considered in the medical and psychological care.
To evaluate expectations regarding treatment and information for sexual dysfunction in women with multiple sclerosis using the SEA-MS-F (Sexual Dysfunction Management and Expectations Assessment in Multiple sclerosis - Female) questionnaire, and to gain an understanding of the relationship between their expectations, demographic factors and medical factors known to promote sexual dysfunction.
A prospective epidemiological, descriptive, analytical, multicentre study was carried out over 15 months on adult women suffering from MS. The SEA-MS-F was used to evaluate expectations regarding their sexuality and sexual activity.
Measure 87 women were included. Mean age was 47 years and the mean time since MS diagnosis was 14 years.
59.8% reported sexual dysfunction, but only 22.4% of the participants had raised the subject with a professional. With regards to expectations, 68% of the women wanted information about sexual dysfunction and 80% of women with sexual difficulties wanted treatment. High expectations correlated with the presence of sexual dysfunction, a regular sexual partner and with milder ambulatory handicap. There were no correlations between expectations and age, time since MS diagnosis, fatigue or being postmenopausal. The SEA-MS-F questionnaire was perceived as useful by 63.4% of the women and 90% felt that it could help doctors to treat sexual dysfunction.
To date, the SEA-MS-F is the only questionnaire validated in women with MS for the evaluation of sexual expectations and in the present study the women felt strongly that it represented a useful way for them to introduce and then discuss the subject of their sexual dysfunction with their doctor. Audrey S-B, Marion R, Béatrice M, et al. Sexual Dysfunction in Women With Multiple Sclerosis: Expectations Regarding Treatment and Information, and Utility of the SEA-MS-F Questionnaire. Sex Med 2022;10:100502.
性功能障碍是多发性硬化症(MS)女性患者的常见主诉,然而在医疗和心理护理中,这个问题常常未被重视。
使用SEA-MS-F(多发性硬化症-女性性功能障碍管理与期望评估)问卷评估多发性硬化症女性患者对性功能障碍治疗及信息的期望,并了解她们的期望、人口统计学因素以及已知会促发性功能障碍的医学因素之间的关系。
对成年多发性硬化症女性患者进行了为期15个月的前瞻性流行病学、描述性、分析性多中心研究。使用SEA-MS-F评估她们对性和性活动的期望。
纳入87名女性。平均年龄为47岁,自确诊多发性硬化症以来的平均时间为14年。
59.8%的患者报告存在性功能障碍,但只有22.4%的参与者曾与专业人员提及过这个问题。关于期望,68%的女性希望获得有关性功能障碍的信息,8